|
⚲
|
| Keyboard |
| Locke Kenneth W
✚
|
|
|---|---|
| CIK # | 0001315264 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001315264] | |
| 4 | [0001315264] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Locke Kenneth W | |
| Evofem Biosciences Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Evofem Biosciences Inc NEOT
Stock Option (Right to Buy) · derivative
|
2016-02-04 | Grant | 35,000 | $0.00 | |
|
Evofem Biosciences Inc NEOT
Common Stock
|
2015-12-17 | Sell | 598 | $1.26 | 753 |
|
Evofem Biosciences Inc NEOT
Common Stock
|
2015-11-18 | Option exercise | 6,098 | $8.30 | 50,613 |
|
Evofem Biosciences Inc NEOT
Stock Option (Right to Buy) · derivative
|
2015-11-18 | Option exercise | 4,093 | $0.00 | |
|
Evofem Biosciences Inc NEOT
Stock Option (Right to Buy) · derivative
|
2015-11-18 | Option exercise | 2,005 | $0.00 | |
|
Evofem Biosciences Inc NEOT
Common Stock
|
2015-11-18 | Sell | 6,098 | $8.30 | 50,613 |
|
Evofem Biosciences Inc NEOT
Stock Option (Right to Buy) · derivative
|
2015-02-10 | Grant | 16,288 | $0.00 |